Stephen F. Petras

879 total citations
10 papers, 711 citations indexed

About

Stephen F. Petras is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Stephen F. Petras has authored 10 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Surgery and 2 papers in Oncology. Recurrent topics in Stephen F. Petras's work include Peroxisome Proliferator-Activated Receptors (3 papers), Cholesterol and Lipid Metabolism (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Stephen F. Petras is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (3 papers), Cholesterol and Lipid Metabolism (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Stephen F. Petras collaborates with scholars based in United States. Stephen F. Petras's co-authors include H. James Harwood, L. E. Casida, Charles E. Chandler, John Vincent, George Chang, Alison H. Varghese, Bruce A. Hay, Lawrence M. Zaccaro, Michael Robbins and James J. Valentine and has published in prestigious journals such as Journal of Biological Chemistry, Applied and Environmental Microbiology and Journal of Lipid Research.

In The Last Decade

Stephen F. Petras

10 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen F. Petras United States 9 340 212 116 101 86 10 711
Jillian L. Pope United States 14 542 1.6× 200 0.9× 113 1.0× 58 0.6× 53 0.6× 18 985
Elena Scotti Switzerland 17 413 1.2× 210 1.0× 132 1.1× 45 0.4× 70 0.8× 23 755
Mary Petrowski United States 8 346 1.0× 392 1.8× 78 0.7× 30 0.3× 106 1.2× 10 731
A. Levanon Israel 12 330 1.0× 147 0.7× 84 0.7× 47 0.5× 45 0.5× 21 650
Sheldon C. Engelhorn United States 7 242 0.7× 178 0.8× 76 0.7× 32 0.3× 167 1.9× 8 684
Recaredo Infante France 12 272 0.8× 201 0.9× 53 0.5× 64 0.6× 108 1.3× 23 623
Maroun Bou Khalil Canada 14 444 1.3× 176 0.8× 79 0.7× 78 0.8× 108 1.3× 17 900
Salisha Hill United States 10 543 1.6× 168 0.8× 56 0.5× 77 0.8× 62 0.7× 14 929
Ronit Ben-Romano Israel 9 465 1.4× 73 0.3× 73 0.6× 66 0.7× 97 1.1× 11 754
M S Levin United States 14 727 2.1× 113 0.5× 37 0.3× 121 1.2× 34 0.4× 15 1.0k

Countries citing papers authored by Stephen F. Petras

Since Specialization
Citations

This map shows the geographic impact of Stephen F. Petras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen F. Petras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen F. Petras more than expected).

Fields of papers citing papers by Stephen F. Petras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen F. Petras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen F. Petras. The network helps show where Stephen F. Petras may publish in the future.

Co-authorship network of co-authors of Stephen F. Petras

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen F. Petras. A scholar is included among the top collaborators of Stephen F. Petras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen F. Petras. Stephen F. Petras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Robbins, Michael, Stephen F. Petras, James J. Valentine, et al.. (2008). Pharmacologic Inhibition of Site 1 Protease Activity Inhibits Sterol Regulatory Element-Binding Protein Processing and Reduces Lipogenic Enzyme Gene Expression and Lipid Synthesis in Cultured Cells and Experimental Animals. Journal of Pharmacology and Experimental Therapeutics. 326(3). 801–808. 108 indexed citations
2.
Luo, Yi, Thomas Sand, Stephen F. Petras, et al.. (2008). Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice. Journal of Lipid Research. 50(8). 1581–1588. 63 indexed citations
3.
Hay, Bruce A., James J. Valentine, Stephen F. Petras, et al.. (2007). Aminopyrrolidineamide inhibitors of site-1 protease. Bioorganic & Medicinal Chemistry Letters. 17(16). 4411–4414. 70 indexed citations
4.
Harwood, H. James, Stephen F. Petras, Dennis J. Hoover, et al.. (2004). Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase. Journal of Lipid Research. 46(3). 547–563. 15 indexed citations
5.
Chandler, Charles E., et al.. (2003). CP-346086. Journal of Lipid Research. 44(10). 1887–1901. 149 indexed citations
7.
Hayward, Cheryl M., E.S. Hamanaka, Robert J. Aiello, et al.. (1997). 2.P.40 Discovery of the squalene synthetase inhibitor CP-340,868. Atherosclerosis. 134(1-2). 125–125. 2 indexed citations
8.
Christman, John W., Stephen F. Petras, Pamela M. Vacek, & Gerald S. Davis. (1989). Rat alveolar macrophage production of chemoattractants for neutrophils: response to Escherichia coli endotoxin. Infection and Immunity. 57(3). 810–816. 23 indexed citations
9.
Christman, John W., et al.. (1988). Alveolar macrophage function is selectively altered after endotoxemia in rats. Infection and Immunity. 56(5). 1254–1259. 19 indexed citations
10.
Petras, Stephen F. & L. E. Casida. (1985). Survival of Bacillus thuringiensis Spores in Soil. Applied and Environmental Microbiology. 50(6). 1496–1501. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026